Rottenberg, Sven

A living biobank of breast cancer organoids captures disease heterogeneity

Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell

Cancer Cells and MetastasisBreast Cancer Treatment Studies

Cited by 1,973

PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer

Pantelidou, C., Sonzogni, O., De Oliveria Taveira, M., Mehta, A. K., Kothari, A., Wang, D., Visal, T., Li, M. K., Pinto, J., Castrillon, J. A., et al. (2019) · Cancer Discovery

PARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers

Cited by 743

Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics

Valdeolivas, A., Amberg, B., Giroud, N., Richardson, M., Gálvez, E. J. C., Badillo, S., Julien-Laferrière, A., Túrós, D., Voith von Voithenberg, L., Wells, I., et al. (2024) · npj Precision Oncology

Single-cell and spatial transcriptomicsColorectal Cancer Treatments and Studies

Cited by 130